Organization
East Hanover, NJ
5 abstracts
Abstract
Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore).Org: Memorial Sloan Kettering Cancer Center, Carolina Urologic Research Center and GenesisCare US, British Columbia Cancer Agency (BCCA), Veterans Prostate Cancer Awareness, Novartis Pharmaceuticals Corporation,
Abstract
Evolution of tisagenlecleucel use for the treatment of pediatric and young adult relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) registry results.Org: Dana-Farber Cancer Institute, Boston Children's Hospital Cancer and Blood Disorders Center, Memorial Sloan Kettering Cancer Center, University of Colorado Denver, Children's Mercy Hospital,
Abstract
Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).Org: University of Iowa Hospitals & Clinics, Carver College of Medicine - University of Iowa, Iowa City, IA, RTI Health Solutions, Research Triangle Park, NC,
Abstract
A FINANCIAL IMPACT ASSESSMENT OF INTRODUCING LUMIRACOXIB ONTO THE FORMULARY OF THE UK NATIONAL HEALTH SERVICE FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITISOrg: Health Economics and Health Services Research, Cerner LifeSciences, Beverly Hills Cancer Care, Novartis Pharmaceuticals Corporation, East Hanover, NJ,
Abstract
A PROSPECTIVE RANDOMIZED 13-WEEK STUDY EVALUATING THE EFFICACY OF LUMIRACOXIB IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEEOrg: University of Texas Southwestern Medical Center, Radiant Research Dallas, Dallas, Miami Research Associates, Miami Cancer Institute - Baptist Health South Florida,